Database for Interstitial Lung Disease

Recruiting

• Conditions: Lung Diseases, Interstitial
• Interventions: Diagnostic Test: chest CT

• Registration Number: NCT04707781
• Lead Sponsor: Medical University of Graz

Brief Summary

The purpose of this study is to establish a clinical database for patients bearing at risk for ILD (Interstitial Lung Disease) and to set up a prospective ILD Screening program for these patients.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2021-01-12
• Study First Submitted QC: 2021-01-12
• Study First Posted: 2021-01-13
• Study Start: 2021-05-01
• Status Verified: 2024-10
• Last Update Submitted: 2024-10-07
• Last Update Posted: 2024-10-09
• Primary Completion: 2026-01-31
• Study Completion: 2026-01-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 412

Inclusion Criteria

• Age: ≥ 18 years
• patients with a known systemic disease bearing a risk for ILD
• signed informed consent (for prospective part)

Exclusion Criteria

• Age < 18 years
• comorbidities severely limiting life-expectancy (e.g. severe cardiovascular conditions, malignant disease)

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
prospective patient cohort	chest CT	patients who will undergo the prospective ILD Screening algorithm
retrospective patient cohort	chest CT	patients with diagnosed ILD

Primary Outcome Measures

Name	Time	Method
DLCO%pred (carbon monoxide diffusing capacity) at time of ILD diagnosis	5 years	The investigators aim to assess DLCO% pred at time of ILD diagnosis in patients undergoing a ILD Screening algorithm and compare to the retrospective patient cohort with diagnosed ILD and the DLCO%pred at time of ILD diagnosis

Secondary Outcome Measures

Name	Time	Method
FVC%pred (Forced vital capacity) at time of ILD diagnosis	5 years	The investigators aim to assess FVC% pred at time of ILD diagnosis in patients undergoing a ILD Screening algorithm and compare to the retrospective patient cohort with diagnosed ILD and the FVC%pred at time of ILD diagnosis

Trial Locations

Locations (1)

Medical University of Graz, Department of Internal Medicine, Division of Pulmonology; 🇦🇹 Graz, Austria